Impiricus Joins MM+M Podcast on the Future of Pharma Interactions

As part of our commitment to physician-first innovation, Impiricus Co-Founder Dr. Osama Hashmi joined MM+M’s Mark Iskowitz and physician Dr. Tamara Greene on a special podcast episode titled The Expected Evolution of Pharma Interactions.

The conversation dives into how pharma can adapt to better meet the real-time needs of HCPs. Hear directly from physicians on the pressing challenges and the critical path forward to building stronger, more impactful partnerships.

Listen to the full episode here: MM+M Podcast

READ OUR CONTENT

News And Insights

New York Stock Exchange Spotlights Impiricus for Unprecedented Impact for Physicians and Pharma

NEW YORK, NY — December 22, 2025 — Impiricus, the leading AI-powered...

Nasdaq Celebrates Impiricus for 30,000% Growth and AI Innovation in Healthcare

NEW YORK, NY — On December 15, 2025, Impiricus, a leader in...

Mike Gelber, Chief Product Officer at Impiricus, Named to MM+M’s 40 Under 40 List

NEW YORK, NY – December 4, 2025 – MM+M has announced its...